In one case a firm is alleged to have improperly billed the COVID-19 Uninsured Program while in the other a firm paid and received kickbacks for unnecessary genetic testing.

A number of the Dutch firm's products have received certification under Europe's In Vitro Diagnostic Regulation recently.